BlaidsX Micro vs EarCentric EX2

The BlaidsX Micro is a budget-priced OTC hearing aid in the visible-in-ear style, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. At $499, it sits in the lowest price tier for the category but ranks #59 of 65 OTC hearing aids tested, placing it in the bottom 11% of the category. In our testing, the BlaidsX Micro delivered mixed results across performance metrics. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5 after tuning—0.46 points above the category average. Speech in quiet performance is slightly above average at 2.9/5, though this represents only mixed absolute quality. However, the device struggles significantly in several areas: speech in noise scores just 1.0/5, falling 0.48 points below average, while own-voice comfort is notably low at 1.0/5, which is 1.51 points below average. Music streaming is a significant weakness, scoring 0.0/5—nearly 2 points below the category average. This makes the BlaidsX Micro unsuitable for users who prioritize streaming audio quality. The device uses disposable batteries rather than rechargeable options. At its $499 price point, several competitors offer stronger overall performance. The Elehear Beyond and Cearvol Wave both deliver higher sound scores at lower prices. The BlaidsX Micro may appeal to budget-conscious consumers who prioritize feedback-free wear and basic speech clarity in quiet environments, but those seeking balanced performance across features—especially streaming or challenging listening situations—should consider alternatives.

The EarCentric EX2 is a budget-priced prescription behind-the-ear hearing aid released in 2021, earning a C grade with a SoundScore of 2.7/5 in HearAdvisor's lab testing. At $218, it ranks #33 of 36 prescription hearing aids tested, placing it in the bottom 11% of its category. In our testing, the EX2 showed a significant split in performance. Feedback handling was excellent at 4.7/5, essentially matching the category average and demonstrating stable operation during movement. However, speech performance was notably limited, with both speech in quiet and speech in noise scoring 1.0/5—well below the category averages of 3.32 and 1.96 respectively. Music streaming scored 0.0/5, falling 2.64 points below the prescription category average of 2.64/5. Own-voice comfort scored 2.3/5, a mixed result that sits 0.45 points below the category average. The device uses a rechargeable battery, which adds convenience for daily use. Notably, tuning did not improve performance in our testing—the Initial and Tuned fit scores were identical at 2.7/5. Budget-conscious shoppers in this price range may want to compare alternatives. The RxEars Rxi scored 4.09/5 at a similar price point, while OTC options like the Audien Hearing Atom offer comparable or better sound performance at lower prices. The EX2 may suit users who prioritize feedback stability and rechargeable convenience over speech clarity, but its limited speech performance is a significant tradeoff.